Arpeggi Overview

  • Founded
  • 2012
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A

Arpeggi General Information


Provider of technology for genome sequencing, data management and computational analysis. The company provides its users the entire process from sample preparation to computational analysis and interpretation, to derive maximal value from genomic data.

Contact Information

Ownership Status
Financing Status
Formerly VC-backed
Primary Industry
Other Healthcare Technology Systems
Other Industries
Business/Productivity Software
Primary Office
  • 4301 West William Cannon Drive
  • Suite B150-140
  • Austin, TX 78749
  • United States
+1 (512) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Arpeggi Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 07-Aug-2013 00000 Completed Startup
1. Early Stage VC 05-Apr-2013 00000 00000 Completed Startup
To view Arpeggi’s complete valuation and funding history, request access »

Arpeggi Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
General Electric Ventures Corporate Venture Capital Minority 000 0000 000000 0
StartUp Health Venture Capital Minority 000 0000 000000 0
To view Arpeggi’s complete investors history, request access »